Intellectia LogoIntellectia
Product
Resources
Stock
Crypto
Pricing
Sign inTry for Free
Intellectia Logo
Sign in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
Crypto Technical Analysis
AI Screener
Trading Strategy
AI Stock Picker
Swing Trading
Earnings Trading
Stock Chart Patterns

Resources

Learn
Blog
Earnings
Tutorial
Company
About Us
Contact
Press
Reward Program
Partner Program
Tools
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
StockCryptoPricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. PTCT
    4. >
  4. Forecast

Stock Price Prediction

-
stocks logo
PTCT
-
$
0.000
0.000(0.000%)
    OverviewForecastTechnicalOptionsEarningsFinancialsValuationInsiders

PTCT Similar Chart Price Prediction

The price of PTCT is predicted to go up -9.16%, based on the high correlation periods with FHN. The similarity of these two price pattern on the periods is 97.67%.

stocks logo

PTCT

stocks logo

FHN

Down: -9.16%Similarity: 97.67%

PTCT Revenue Forecast

PTCT EPS Forecast

PTCT FAQs

What is bull’s view on PTCT?

PTC Therapeutics (PTCT) has a bullish outlook with analysts maintaining a "Buy" rating and an average price target of $55.25, representing a 21.9% upside from its current price of $45.25. RBC Capital is particularly optimistic, setting a $60 target, citing strong revenue growth and a promising pipeline in rare diseases and oncology. Cantor Fitzgerald also highlights PTCT as a top pick for 2025, projecting significant upside driven by its phenylketonuria and Huntington's disease programs.

What is bear's view on PTCT?

PTCT stock faces bearish sentiment due to insider selling, including the CEO's recent share disposal, and a GAAP net loss of $106.65M in the last quarter. Analysts like Citigroup maintain a Sell rating with a $32 price target, reflecting a potential downside from its current price of $45.25. Additionally, regulatory and pipeline uncertainties weigh on the stock's outlook.

What is PTCT revenue forecast for next quarter？

The market consensus for PTCT's revenue in the upcoming quarter is projected to be approximately $445.937M USD.

PTCT VS S&P500

Ask Intellectia about PTCT

PTCT Analyst's Forecast

David Lebowitz

Citigroup

Strong Sell

2025-02-12

Price Target

$32 → $45

Downside

-8.03%

Citi raised the firm's price target on PTC Therapeutics to $45 from $32 and keeps a Sell rating on the shares. The firm updated the company's model following the recent closure of the deal with Novartis for PTC518 as well as recent pipeline updates. However, Citi believes PTC's upcoming catalysts have some risk.
Kristen Kluska

Cantor Fitzgerald

Buy

2025-01-15

Price Target

$80 → $76

Upside

+79.8%

Jeffrey Hung

Morgan Stanley

Hold → Buy

2024-12-13

Price Target

$45 → $67

Upside

+44.49%

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerCrypto Technical AnalysisAI Screener
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings Trading
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySitemap
Start for Free

Hot Stocks

stocks logo

ASB

Associated Banc-Corp

$24.51
1.32%
stocks logo

GSHD

Goosehead Insurance Inc

$122.82
0.30%
stocks logo

AI

C3.ai Inc

$26.44
0.42%
stocks logo

GBDC

Golub Capital Bdc Inc

$15.56
-0.83%
stocks logo

FLO

Flowers Foods Inc

$18.93
-2.07%
stocks logo

NWL

Newell Brands Inc

$6.66
-1.62%
stocks logo

OGN

Organon & Co

$15.48
-4.03%
stocks logo

PRCT

Procept Biorobotics Corp

$68.11
8.61%
stocks logo

IBOC

International Bancshares Corp

$65.41
-0.24%
stocks logo

OGS

ONE Gas Inc

$74.79
0.20%